Start Publications HIV-cell membrane fusion intermediates are restricted by ...
KSV NIMA

HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy

Year: 2020

Journal: J. Biol. Chem., Volume 295, NOV 6, page 15183–15195

Authors: Ward, AE; Kiessling, V; Pornillos, O; White, JM; Ganser-Pornillos, BK; Tamm, LK

Organizations: National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AI030557, F30 HD101348, P50 AI150464]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U24 GM116790]

Keywords: HIV; membrane fusion; virus entry; host-pathogen interaction; cryo-electron microscopy; single-particle tracking; human immunodeficiency virus (HIV)

To enter a cell and establish infection, HIV must first fuse its lipid envelope with the host cell plasma membrane. Whereas the process of HIV membrane fusion can be tracked by fluorescence microscopy, the 3D configuration of proteins and lipids at intermediate steps can only be resolved with cryo-electron tomography (cryoET). However, cryoET of whole cells is technically difficult. To overcome this problem, we have adapted giant plasma membrane vesicles (or blebs) from native cell membranes expressing appropriate receptors as targets for fusion with HIV envelope glycoprotein-expressing pseudovirus particles with and without Serinc host restriction factors. The fusion behavior of these particles was probed by TIRF microscopy on bleb-derived supported membranes. Timed snapshots of fusion of the same particles with blebs were examined by cryo-ET. The combination of these methods allowed us to characterize the structures of various intermediates on the fusion pathway and showed that when Serinc3 or Serinc5 (but not Serinc2) were present, later fusion products were more prevalent, suggesting that Serinc3/5 act at multiple steps to prevent progression to full fusion. In addition, the antifungal amphotericin B reversed Serinc restriction, presumably by intercalation into the fusing membranes. Our results provide a highly detailed view of Serinc restriction of HIV-cell membrane fusion and thus extend current structural and functional information on Serinc as a lipid-binding protein.